Incidental meningioma management

Initial Assessment:

Confirm diagnosis with MRI (including contrast-enhanced sequences).

Rule out alternative diagnoses (e.g., metastasis, hemangiopericytoma).

Document baseline size, location, and radiological features (e.g., calcifications, edema, dural tail, brain invasion).

Risk Stratification: Factors predicting progression include:

Tumor size > 3 cm

Skull base or eloquent location

Absence of calcification

Peritumoral edema

Hyperintensity on T2

Rapid growth on serial imaging

see Incidental meningioma active surveillance

Most common approach for small, asymptomatic tumors.

Serial MRIs: every 6 months initially, then yearly if stable.

Considered for tumors showing growth, causing mass effect, or in younger patients where long-term monitoring is less ideal.

Also considered if tumor is accessible with low expected morbidity.

Stereotactic radiosurgery (SRS) or fractionated radiotherapy may be offered in selected cases.

Typically reserved for growing lesions not amenable to surgery or in older/frail patients.

No universal consensus, but typically:

MRI at 6 months after diagnosis

If stable: yearly imaging for 5 years, then spacing out

Lifelong follow-up is generally advised for younger patients

Patient age and comorbidities

Tumor location and size

Radiological features of aggressiveness

Patient preference and anxiety levels

Life expectancy and quality of life impact

  • incidental_meningioma_management.txt
  • Last modified: 2025/04/03 21:23
  • by 127.0.0.1